Bharat biotech, Biotechnology company

In his interaction with Chief Ministers of several states, Prime Minister Narendra Modi on Wednesday warned that the Covid-19 crisis has not yet been overcome, stressing the importance of prioritising administration of vaccines to every eligible child at the earliest and the need to ensure Covid-appropriate behaviour in public places."Schools have reopened in the country after a long time. In such a situation, families are concerned about rising COVID-19 cases. It is our priority to inoculate all eligible children as soon as possible," said PM Modi after the meetingTo achieve the said goal, the prime minister said that there was a need to run special campaigns over COVID-19 vaccination in schools."We need to ensure that parents and teachers are aware of such initiative," he added."Despite managing the COVID crisis well as compared to other countries, we can see cases' uptick in states now. We have to stay alert. It's clear that the COVID challenge has yet not been surpassed," the prime minister said.PM Modi's statements come a day after the Drugs Controller General of India (DCGI) granted an emergency use authorization (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.COVID-19 vaccination for the age group 12-14 years was started on March 16, 2022. So far 2,75,34,619 adolescents have been administered the first dose of the COVID-19 vaccine and 43,87,961 have received the second dose.Children from age of group of 15-18 has received 5,82,59,733 first dose and 4,17,47,337 second dose.Meanwhile, India's COVID-19 vaccination coverage has exceeded 188.19 Cr (1,88,19,40,971) as per provisional reports till 7 am today, as per the official statement on Wednesday. India's Active Caseload currently stands at 16,279. Active cases now constitute 0.04 per cent of the country's total Positive Cases.Consequently, India's recovery rate stands at 98.75 per cent. 2,252 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,25,25,563. India recorded 2,483 new COVID-19 cases on Tuesday.Meanwhile, at the review meeting chaired by the Prime Minister, Union Home Ministers Amit Shah, Unnion Health Minister Mansukh Mandaviya as well as chief ministers of Punjab, Chhattisgarh, Tripura and others were present.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Bharat BiotechFOLLOW

Bharat biotech, Latest News

Hyderabad, Aug 15 Vaccine-maker Bharat Biotech announced on Monday that its intranasal vaccine for Covid-19 has been proven ... ...

Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers. ...

Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against both homo ...

New Delhi, June 17 Hyderabad-based vaccine manufacturer Bharat Biotech on Friday announced that its whole-virion inactivated Covid vaccine ... ...

New Delhi, May 4 Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of ... ...

Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said. ...

The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval (EUA) nod for its COVID jab, ...

In his interaction with Chief Ministers of several states, Prime Minister Narendra Modi on Wednesday warned that the Covid-19 crisis has not yet been overcome, stressing the importance of prioritising administration of vaccines to every eligible chil ...